319 related articles for article (PubMed ID: 32744879)
1. Review of high dose vancomycin in the treatment of
Bader MS; Hawboldt J; Main C; Mertz D; Loeb M; Farrell A; Joyce J
Infect Dis (Lond); 2020; 52(12):847-857. PubMed ID: 32744879
[TBL] [Abstract][Full Text] [Related]
2. Does Addition of Intravenous Metronidazole to Oral Vancomycin Improve Outcomes in Clostridioides difficile Infection?
Wang Y; Schluger A; Li J; Gomez-Simmonds A; Salmasian H; Freedberg DE
Clin Infect Dis; 2020 Dec; 71(9):2414-2420. PubMed ID: 31714955
[TBL] [Abstract][Full Text] [Related]
3. Use of Oral Vancomycin for Clostridioides difficile Infection and the Risk of Vancomycin-Resistant Enterococci.
Stevens VW; Khader K; Echevarria K; Nelson RE; Zhang Y; Jones M; Timbrook TT; Samore MH; Rubin MA
Clin Infect Dis; 2020 Jul; 71(3):645-651. PubMed ID: 31504328
[TBL] [Abstract][Full Text] [Related]
4. Effective Dosage of Oral Vancomycin in Treatment for Initial Episode of
Chiu CY; Sarwal A; Feinstein A; Hennessey K
Antibiotics (Basel); 2019 Oct; 8(4):. PubMed ID: 31581576
[No Abstract] [Full Text] [Related]
5. Outcomes associated with recent guideline recommendations removing metronidazole for treatment of non-severe Clostridioides difficile infection: a retrospective, observational, nationwide cohort study.
Gentry CA; Campbell DL; Williams RJ
Int J Antimicrob Agents; 2021 Mar; 57(3):106282. PubMed ID: 33465458
[TBL] [Abstract][Full Text] [Related]
6. Impact of Oral Metronidazole, Vancomycin, and Fidaxomicin on Host Shedding and Environmental Contamination With Clostridioides difficile.
Turner NA; Warren BG; Gergen-Teague MF; Addison RM; Addison B; Rutala WA; Weber DJ; Sexton DJ; Anderson DJ
Clin Infect Dis; 2022 Mar; 74(4):648-656. PubMed ID: 34017999
[TBL] [Abstract][Full Text] [Related]
7. Changes in Metronidazole and Vancomycin Utilization for Nonsevere Clostridioides difficile Infection Among Institutions Caring for Children.
Stultz JS; Hopp J; Orndahl CM; Omecene NE; Pakyz AL
Pediatr Infect Dis J; 2021 Jul; 40(7):634-636. PubMed ID: 33657601
[TBL] [Abstract][Full Text] [Related]
8. Fidaxomicin versus metronidazole, vancomycin and their combination for initial episode, first recurrence and severe Clostridioides difficile infection - An observational cohort study.
Polivkova S; Krutova M; Capek V; Sykorova B; Benes J
Int J Infect Dis; 2021 Feb; 103():226-233. PubMed ID: 33188906
[TBL] [Abstract][Full Text] [Related]
9. A meta-analysis of metronidazole and vancomycin for the treatment of Clostridium difficile infection, stratified by disease severity.
Di X; Bai N; Zhang X; Liu B; Ni W; Wang J; Wang K; Liang B; Liu Y; Wang R
Braz J Infect Dis; 2015; 19(4):339-49. PubMed ID: 26001980
[TBL] [Abstract][Full Text] [Related]
10. Critique of "Evaluation of Addition of Intravenous Metronidazole to Oral Vancomycin Therapy in Critically Ill Patients with Non-Fulminant Severe Clostridioides difficile Infection".
Ito H
Pharmacotherapy; 2020 Sep; 40(9):984. PubMed ID: 33112453
[No Abstract] [Full Text] [Related]
11. Surgical Infection Society Guidelines for Total Abdominal Colectomy versus Diverting Loop Ileostomy with Antegrade Intra-Colonic Lavage for the Surgical Management of Severe or Fulminant, Non-Perforated
Forrester JD; Colling KP; Diaz JJ; Faliks B; Kim PK; Tessier JM; Tung J; Huston JM
Surg Infect (Larchmt); 2022 Mar; 23(2):97-104. PubMed ID: 34619068
[No Abstract] [Full Text] [Related]
12. Vancomycin Versus Metronidazole for Nonsevere
Sarna KV; Gross AE
Ann Pharmacother; 2019 Aug; 53(8):845-852. PubMed ID: 30734567
[No Abstract] [Full Text] [Related]
13. Pharmacological Management of Pediatric Clostridioides difficile Infection: Clarifying the Controversies.
DeVine MN; MacBrayne CE; Child J; Blackmer AB
J Pediatr Health Care; 2022; 36(2):181-192. PubMed ID: 34412953
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic Effects of Bifidobacterium breve YH68 in Combination with Vancomycin and Metronidazole in a Primary Clostridioides difficile-Infected Mouse Model.
Yang J; Meng L; Yang H
Microbiol Spectr; 2022 Apr; 10(2):e0067222. PubMed ID: 35311540
[TBL] [Abstract][Full Text] [Related]
15. Emergence of Clinical Clostridioides difficile Isolates With Decreased Susceptibility to Vancomycin.
Darkoh C; Keita K; Odo C; Oyaro M; Brown EL; Arias CA; Hanson BM; DuPont HL
Clin Infect Dis; 2022 Jan; 74(1):120-126. PubMed ID: 35016207
[TBL] [Abstract][Full Text] [Related]
16. Oral vancomycin versus metronidazole for the treatment of Clostridioides difficile infection: Meta-analysis of randomized controlled trials.
Igarashi Y; Tashiro S; Enoki Y; Taguchi K; Matsumoto K; Ohge H; Suzuki H; Nakamura A; Mori N; Morinaga Y; Yamagishi Y; Yoshizawa S; Yanagihara K; Mikamo H; Kunishima H
J Infect Chemother; 2018 Nov; 24(11):907-914. PubMed ID: 30170735
[TBL] [Abstract][Full Text] [Related]
17. Optimal therapeutic recommendation for Clostridioides difficile infection in pediatric and adolescent populations: a systematic review and meta-analysis.
Tashiro S; Mihara T; Okawa R; Tanaka Y; Samura M; Enoki Y; Taguchi K; Matsumoto K; Yamagishi Y
Eur J Pediatr; 2023 Jun; 182(6):2673-2681. PubMed ID: 37000258
[TBL] [Abstract][Full Text] [Related]
18. Retrospective study of the efficacy and safety of metronidazole and vancomycin for Clostridioides difficile infection.
Misawa K; Iketani O; Enoki Y; Taguchi K; Uno S; Uwamino Y; Hasegawa N; Matsumoto K
J Infect Chemother; 2021 Oct; 27(10):1407-1412. PubMed ID: 34023223
[TBL] [Abstract][Full Text] [Related]
19. Antibiotic Therapies for Clostridioides difficile Infection in Children.
Gonzales-Luna AJ; Carlson TJ; Garey KW
J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S52-S57. PubMed ID: 34791393
[TBL] [Abstract][Full Text] [Related]
20. Intravenous metronidazole for fulminant Clostridioides difficile infection.
Pipitone G; Granata G; Sartelli M; Gizzi A; Imburgia C; Cascio A; Iaria C
Clin Microbiol Infect; 2023 May; 29(5):656-657. PubMed ID: 36739974
[No Abstract] [Full Text] [Related]
[Next] [New Search]
